Wilbanks Smith & Thomas Asset Management LLC grew its stake in shares of Colgate-Palmolive (NYSE:CL) by 1.0% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 50,227 shares of the company’s stock after buying an additional 494 shares during the quarter. Wilbanks Smith & Thomas Asset Management LLC’s holdings in Colgate-Palmolive were worth $3,723,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Pacer Advisors Inc. boosted its position in Colgate-Palmolive by 8.4% during the second quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock valued at $1,499,000 after acquiring an additional 1,566 shares during the last quarter. Alliancebernstein L.P. boosted its position in Colgate-Palmolive by 4.2% during the first quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock valued at $139,014,000 after acquiring an additional 77,414 shares during the last quarter. Israel Discount Bank of New York bought a new stake in Colgate-Palmolive during the first quarter valued at $1,349,000. Principal Financial Group Inc. boosted its position in Colgate-Palmolive by 0.6% during the first quarter. Principal Financial Group Inc. now owns 1,271,008 shares of the company’s stock valued at $93,025,000 after acquiring an additional 7,905 shares during the last quarter. Finally, Personal Capital Advisors Corp boosted its position in Colgate-Palmolive by 5.8% during the second quarter. Personal Capital Advisors Corp now owns 394,028 shares of the company’s stock valued at $29,209,000 after acquiring an additional 21,456 shares during the last quarter. 72.96% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive (CL) opened at $73.20 on Friday. Colgate-Palmolive has a fifty-two week low of $63.43 and a fifty-two week high of $77.27. The firm has a market cap of $65,199.31, a PE ratio of 25.87, a PEG ratio of 3.40 and a beta of 0.81. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting the consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The firm had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same quarter in the prior year, the business earned $0.73 earnings per share. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. sell-side analysts forecast that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were issued a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, October 20th. This represents a $1.60 annualized dividend and a dividend yield of 2.19%. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.

In related news, insider Victoria L. Dolan sold 9,000 shares of the company’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total value of $660,690.00. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CMO Mukul Deoras sold 7,500 shares of the company’s stock in a transaction dated Friday, November 10th. The stock was sold at an average price of $73.28, for a total transaction of $549,600.00. Following the completion of the sale, the chief marketing officer now owns 45,217 shares in the company, valued at approximately $3,313,501.76. The disclosure for this sale can be found here. Insiders have sold 173,673 shares of company stock worth $12,629,293 in the last quarter. Company insiders own 1.02% of the company’s stock.

A number of analysts have commented on the stock. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, October 17th. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. SunTrust Banks raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their price target for the company from $65.00 to $85.00 in a research report on Wednesday, October 11th. Societe Generale cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price target on the stock. in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Two research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and four have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $76.04.

ILLEGAL ACTIVITY WARNING: This news story was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2017/12/08/wilbanks-smith-thomas-asset-management-llc-boosts-holdings-in-colgate-palmolive-cl.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related stocks with our FREE daily email newsletter.